These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 16543236)

  • 21. Fibrosis and hypoxia-inducible factor-1α-dependent tumors of the soft tissue on loss of von Hippel-Lindau in mesenchymal progenitors.
    Mangiavini L; Merceron C; Araldi E; Khatri R; Gerard-O'Riley R; Wilson TL; Sandusky G; Abadie J; Lyons KM; Giaccia AJ; Schipani E
    Am J Pathol; 2015 Nov; 185(11):3090-101. PubMed ID: 26348575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The N-terminal transactivation domain confers target gene specificity of hypoxia-inducible factors HIF-1alpha and HIF-2alpha.
    Hu CJ; Sataur A; Wang L; Chen H; Simon MC
    Mol Biol Cell; 2007 Nov; 18(11):4528-42. PubMed ID: 17804822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down-regulation of HIF-1alpha by oncolytic reovirus infection independently of VHL and p53.
    Cho IR; Koh SS; Min HJ; Park EH; Ratakorn S; Jhun BH; Jeong SH; Yoo YH; Youn HD; Johnston RN; Chung YH
    Cancer Gene Ther; 2010 May; 17(5):365-72. PubMed ID: 20075985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MAPK signaling up-regulates the activity of hypoxia-inducible factors by its effects on p300.
    Sang N; Stiehl DP; Bohensky J; Leshchinsky I; Srinivas V; Caro J
    J Biol Chem; 2003 Apr; 278(16):14013-9. PubMed ID: 12588875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia-inducible factor-2α stabilizes the von Hippel-Lindau (VHL) disease suppressor, Myb-related protein 2.
    Okumura F; Joo-Okumura A; Nakatsukasa K; Kamura T
    PLoS One; 2017; 12(4):e0175593. PubMed ID: 28394947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein.
    Cockman ME; Masson N; Mole DR; Jaakkola P; Chang GW; Clifford SC; Maher ER; Pugh CW; Ratcliffe PJ; Maxwell PH
    J Biol Chem; 2000 Aug; 275(33):25733-41. PubMed ID: 10823831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesis.
    Semenza GL
    Blood; 2009 Sep; 114(10):2015-9. PubMed ID: 19494350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of hepatic fibrosis by overexpression of von Hippel-Lindau protein in experimental models of chronic liver disease.
    Wang J; Lu Z; Xu Z; Tian P; Miao H; Pan S; Song R; Sun X; Zhao B; Wang D; Ma Y; Song X; Zhang S; Liu L; Jiang H
    Sci Rep; 2017 Jan; 7():41038. PubMed ID: 28112200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
    Blancher C; Moore JW; Robertson N; Harris AL
    Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AK-1, a SIRT2 inhibitor, destabilizes HIF-1α and diminishes its transcriptional activity during hypoxia.
    Lee SD; Kim W; Jeong JW; Park JW; Kim JE
    Cancer Lett; 2016 Apr; 373(1):138-145. PubMed ID: 26808575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphorylation of von Hippel-Lindau protein by checkpoint kinase 2 regulates p53 transactivation.
    Roe JS; Kim HR; Hwang IY; Ha NC; Kim ST; Cho EJ; Youn HD
    Cell Cycle; 2011 Nov; 10(22):3920-8. PubMed ID: 22071692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kelch-like 20 up-regulates the expression of hypoxia-inducible factor-2α through hypoxia- and von Hippel-Lindau tumor suppressor protein-independent regulatory mechanisms.
    Higashimura Y; Terai T; Yamaji R; Mitani T; Ogawa M; Harada N; Inui H; Nakano Y
    Biochem Biophys Res Commun; 2011 Sep; 413(2):201-5. PubMed ID: 21888897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metastasis-associated protein 1 enhances stability of hypoxia-inducible factor-1alpha protein by recruiting histone deacetylase 1.
    Yoo YG; Kong G; Lee MO
    EMBO J; 2006 Mar; 25(6):1231-41. PubMed ID: 16511565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The lncRNA MALAT1, acting through HIF-1α stabilization, enhances arsenite-induced glycolysis in human hepatic L-02 cells.
    Luo F; Liu X; Ling M; Lu L; Shi L; Lu X; Li J; Zhang A; Liu Q
    Biochim Biophys Acta; 2016 Sep; 1862(9):1685-95. PubMed ID: 27287256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Constitutive/hypoxic degradation of HIF-alpha proteins by the proteasome is independent of von Hippel Lindau protein ubiquitylation and the transactivation activity of the protein.
    Kong X; Alvarez-Castelao B; Lin Z; Castaño JG; Caro J
    J Biol Chem; 2007 May; 282(21):15498-505. PubMed ID: 17403672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. (1)H NMR metabolomics analysis of renal cell carcinoma cells: Effect of VHL inactivation on metabolism.
    Cuperlovic-Culf M; Cormier K; Touaibia M; Reyjal J; Robichaud S; Belbraouet M; Turcotte S
    Int J Cancer; 2016 May; 138(10):2439-49. PubMed ID: 26620126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of von Hippel-Lindau protein synergizes with doxorubicin to suppress hepatocellular carcinoma in mice.
    Wang J; Ma Y; Jiang H; Zhu H; Liu L; Sun B; Pan S; Krissansen GW; Sun X
    J Hepatol; 2011 Aug; 55(2):359-68. PubMed ID: 21168458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53 stabilization and transactivation by a von Hippel-Lindau protein.
    Roe JS; Kim H; Lee SM; Kim ST; Cho EJ; Youn HD
    Mol Cell; 2006 May; 22(3):395-405. PubMed ID: 16678111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic regulators: multifunctional proteins modulating hypoxia-inducible factor-α protein stability and activity.
    Luo W; Wang Y
    Cell Mol Life Sci; 2018 Mar; 75(6):1043-1056. PubMed ID: 29032501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. VHL and HIF signalling in renal cell carcinogenesis.
    Baldewijns MM; van Vlodrop IJ; Vermeulen PB; Soetekouw PM; van Engeland M; de Bruïne AP
    J Pathol; 2010 Jun; 221(2):125-38. PubMed ID: 20225241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.